Seizert Capital Partners LLC Has $2.09 Million Stake in Chemed Corp. (CHE)
Seizert Capital Partners LLC lessened its holdings in shares of Chemed Corp. (NYSE:CHE) by 60.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,356 shares of the company’s stock after selling 15,713 shares during the quarter. Seizert Capital Partners LLC owned approximately 0.06% of Chemed Corp. worth $2,092,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also modified their holdings of CHE. Acrospire Investment Management LLC purchased a new position in shares of Chemed Corp. during the 2nd quarter worth $120,000. Pacad Investment Ltd. raised its position in shares of Chemed Corp. by 250.0% during the 2nd quarter. Pacad Investment Ltd. now owns 700 shares of the company’s stock valued at $143,000 after purchasing an additional 500 shares during the period. IFP Advisors Inc raised its position in shares of Chemed Corp. by 1,504.5% during the 3rd quarter. IFP Advisors Inc now owns 706 shares of the company’s stock valued at $143,000 after purchasing an additional 662 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Chemed Corp. by 12.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 731 shares of the company’s stock valued at $150,000 after purchasing an additional 83 shares during the period. Finally, MCF Advisors LLC bought a new stake in shares of Chemed Corp. during the 3rd quarter valued at $152,000. Institutional investors and hedge funds own 97.24% of the company’s stock.
Several analysts have recently commented on CHE shares. KeyCorp restated a “hold” rating on shares of Chemed Corp. in a research report on Friday, October 27th. Zacks Investment Research downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Royal Bank Of Canada restated a “hold” rating and set a $209.00 price objective on shares of Chemed Corp. in a research report on Tuesday, October 3rd. BidaskClub downgraded shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. raised their price objective on shares of Chemed Corp. from $220.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 27th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Chemed Corp. presently has an average rating of “Hold” and an average target price of $236.00.
Shares of Chemed Corp. (NYSE CHE) traded up $10.56 during midday trading on Friday, reaching $235.01. 126,539 shares of the company’s stock were exchanged, compared to its average volume of 92,810. The company has a market capitalization of $3.67 billion, a P/E ratio of 28.31, a P/E/G ratio of 4.86 and a beta of 1.14. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.48 and a current ratio of 0.50.
Chemed Corp. (NYSE:CHE) last announced its quarterly earnings data on Thursday, October 26th. The company reported $2.15 EPS for the quarter, topping the Zacks’ consensus estimate of $2.00 by $0.15. Chemed Corp. had a return on equity of 27.69% and a net margin of 4.62%. The firm had revenue of $417.40 million during the quarter, compared to analyst estimates of $414.34 million. During the same period last year, the company posted $1.73 EPS. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. analysts forecast that Chemed Corp. will post 4.73 EPS for the current year.
The firm also recently disclosed a dividend, which will be paid on Monday, December 4th. Shareholders of record on Monday, November 13th will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, November 10th. Chemed Corp.’s payout ratio is presently 24.89%.
In other news, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $228.45, for a total transaction of $228,450.00. Following the completion of the sale, the executive vice president now directly owns 36,809 shares of the company’s stock, valued at approximately $8,409,016.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick P. Grace sold 500 shares of the firm’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $201.48, for a total value of $100,740.00. Following the sale, the director now directly owns 4,515 shares of the company’s stock, valued at $909,682.20. The disclosure for this sale can be found here. Insiders have sold a total of 13,250 shares of company stock valued at $2,927,418 over the last 90 days. Corporate insiders own 4.90% of the company’s stock.
WARNING: “Seizert Capital Partners LLC Has $2.09 Million Stake in Chemed Corp. (CHE)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/seizert-capital-partners-llc-has-2-09-million-stake-in-chemed-corp-che/1678379.html.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.